Skip to content
Review

Dissecting Epigenetic Drug Response Mechanisms Using CRISPR Knockout Screens.

2026 · Methods in molecular biology · Vol 3005, pp. 383-401 · 0 citations
Medicine

TL;DR

An overview of the CRISPR screen methodology, which involves introducing guide RNAs targeting specific genes into cells, followed by phenotype selection and analysis, is presented, providing valuable insights into gene function and potential therapeutic targets.

View source

Similar papers

Review Open access Aug 2026

CRISPR-Cas9 gene editing approaches in colorectal cancer: Current progress and future prospects.

Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, characterized by genetic heterogeneity and the accumulation of mutations in key oncogenes and tumor suppressor genes. CRISPR-Cas9 technology has greatly advanced genetic research by enabling precise genome editing. This review focuses on the...

Mohadeseh Hassannia, P. Amirifar · 0 citations
Jul 2026

Epigenome-Wide CRISPR-Cas9-Based Knockout Screens on Chemoresistant Cells.

Key methodological steps for achieving high-efficiency lentiviral transduction and selection are described, enabling the successful application of EPIKOL CRISPR screens in chemoresistant TNBC models.

O. Yedier-Bayram, Elif Ayca Guvener, T. Bagci-Onder · 0 citations
Review Jul 2026

CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics.

How CRISPR-enabled functional genomics approaches can reveal unexpected cancer dependencies and resistance mechanisms is outlined, and emerging applications of CRISPR-based diagnostics in oncology that convert precise nucleic acid sequence recognition into rapid mutation detection are discussed.

S. Grigg, Carolyn Shembrey, M. Fareh et al. · 1 citation
Aug 2026

Epigenetic Modifiers and Synthetic Lethality in Cancer Therapy: Emerging Targets Beyond Traditional Approaches.

The convergence of epigenetic modulators with synthetic-lethality-based therapeutic architectures is poised to define a transformative paradigm in precision oncology by orchestrating multilayered perturbations across chromatin-regulatory networks, DNA damage-response pathways, and context-specific vulnerability nodes.

Venkatesh Kamath, Vasudev R. Pai, Bhavana Bhat et al. · 0 citations
Review Open access Jul 2026

CRISPR/Cas9 in cancer therapy: clinical translation, mechanistic strategies, and therapeutic directions

Overall, CRISPR/Cas9 represents a promising yet evolving platform in oncology, with its future clinical success dependent on achieving a balance between precision, safety, scalability, and long-term therapeutic durability.

C. Ng, Sakina Mustafa, X. Y. Yap et al. · 0 citations
Review Aug 2026

Targeting the Hallmarks of Ageing: Pharmacological Challenges and Breakthroughs in CRISPR Delivery Systems and Future Prospects.

CRISPR has emerged as a next-generation gene-editing tool with the potential to target the molecular pathways associated with ageing and related disorders. It functions through RNA-guided Cas nucleases, directing DNA cleavage and utilizing the native DNA repair machinery for genetic manipulations. Advances in CRISPR te...

Sakshi Rathore, Akash Gupta, Kamal Shah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.